Product Code: ETC6748704 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Non-Hodgkin Lymphoma Diagnostics Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 China Non-Hodgkin Lymphoma Diagnostics Market - Industry Life Cycle |
3.4 China Non-Hodgkin Lymphoma Diagnostics Market - Porter's Five Forces |
3.5 China Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume Share, By Test Type, 2021 & 2031F |
3.6 China Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume Share, By Cancer Stage, 2021 & 2031F |
3.7 China Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume Share, By Tumor Type, 2021 & 2031F |
3.8 China Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.9 China Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.10 China Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.11 China Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 China Non-Hodgkin Lymphoma Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing incidence of non-Hodgkin lymphoma in China |
4.2.2 Growing awareness and early detection of the disease |
4.2.3 Advancements in diagnostic technologies and procedures |
4.3 Market Restraints |
4.3.1 High cost associated with diagnostic tests and treatments |
4.3.2 Limited availability of specialized healthcare facilities in certain regions of China |
4.3.3 Stringent regulatory requirements for approval of diagnostic products |
5 China Non-Hodgkin Lymphoma Diagnostics Market Trends |
6 China Non-Hodgkin Lymphoma Diagnostics Market, By Types |
6.1 China Non-Hodgkin Lymphoma Diagnostics Market, By Test Type |
6.1.1 Overview and Analysis |
6.1.2 China Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Test Type, 2021- 2031F |
6.1.3 China Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Imaging, 2021- 2031F |
6.1.4 China Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Biopsy, 2021- 2031F |
6.1.5 China Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Immunohistochemistry, 2021- 2031F |
6.1.6 China Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Biomarker Test, 2021- 2031F |
6.1.7 China Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Genetic Test, 2021- 2031F |
6.1.8 China Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Cytogenetics, 2021- 2031F |
6.1.9 China Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Others, 2021- 2031F |
6.1.10 China Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Others, 2021- 2031F |
6.2 China Non-Hodgkin Lymphoma Diagnostics Market, By Cancer Stage |
6.2.1 Overview and Analysis |
6.2.2 China Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Stage 0, 2021- 2031F |
6.2.3 China Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Stage I, 2021- 2031F |
6.2.4 China Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Stage Ii, 2021- 2031F |
6.2.5 China Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Stage Iii, 2021- 2031F |
6.2.6 China Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Stage Iv, 2021- 2031F |
6.3 China Non-Hodgkin Lymphoma Diagnostics Market, By Tumor Type |
6.3.1 Overview and Analysis |
6.3.2 China Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Aggressive Lymphomas, 2021- 2031F |
6.3.3 China Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Indolent Lymphomas, 2021- 2031F |
6.4 China Non-Hodgkin Lymphoma Diagnostics Market, By Product |
6.4.1 Overview and Analysis |
6.4.2 China Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Instrument Based Products, 2021- 2031F |
6.4.3 China Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Platform Based Products, 2021- 2031F |
6.4.4 China Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Kits And Reagents, 2021- 2031F |
6.4.5 China Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Other Consumables, 2021- 2031F |
6.5 China Non-Hodgkin Lymphoma Diagnostics Market, By Technology |
6.5.1 Overview and Analysis |
6.5.2 China Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Fluorescent In Situ Hybridization, 2021- 2031F |
6.5.3 China Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Next Generation Sequencing, 2021- 2031F |
6.5.4 China Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Fluorimmunoassay, 2021- 2031F |
6.5.5 China Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Comparative Genomic Hybridization, 2021- 2031F |
6.5.6 China Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Immunohistochemical, 2021- 2031F |
6.5.7 China Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Others, 2021- 2031F |
6.6 China Non-Hodgkin Lymphoma Diagnostics Market, By Application |
6.6.1 Overview and Analysis |
6.6.2 China Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Screening, 2021- 2031F |
6.6.3 China Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Diagnostic And Predictive, 2021- 2031F |
6.6.4 China Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Prognostic, 2021- 2031F |
6.6.5 China Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Research, 2021- 2031F |
6.7 China Non-Hodgkin Lymphoma Diagnostics Market, By End User |
6.7.1 Overview and Analysis |
6.7.2 China Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.7.3 China Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Diagnostic Centers, 2021- 2031F |
6.7.4 China Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Academic Institutes, 2021- 2031F |
6.7.5 China Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Academic Institutes, 2021- 2031F |
6.7.6 China Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Ambulatory Surgical Centers, 2021- 2031F |
6.7.7 China Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Others, 2021- 2031F |
6.8 China Non-Hodgkin Lymphoma Diagnostics Market, By Distribution Channel |
6.8.1 Overview and Analysis |
6.8.2 China Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Direct Tender, 2021- 2031F |
6.8.3 China Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Retail Sales, 2021- 2031F |
6.8.4 China Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By , 2021- 2031F |
7 China Non-Hodgkin Lymphoma Diagnostics Market Import-Export Trade Statistics |
7.1 China Non-Hodgkin Lymphoma Diagnostics Market Export to Major Countries |
7.2 China Non-Hodgkin Lymphoma Diagnostics Market Imports from Major Countries |
8 China Non-Hodgkin Lymphoma Diagnostics Market Key Performance Indicators |
8.1 Average time to diagnose non-Hodgkin lymphoma cases |
8.2 Adoption rate of advanced diagnostic technologies |
8.3 Number of healthcare facilities offering non-Hodgkin lymphoma diagnostics |
8.4 Patient survival rates post-diagnosis |
8.5 Rate of reimbursement for non-Hodgkin lymphoma diagnostic tests |
9 China Non-Hodgkin Lymphoma Diagnostics Market - Opportunity Assessment |
9.1 China Non-Hodgkin Lymphoma Diagnostics Market Opportunity Assessment, By Test Type, 2021 & 2031F |
9.2 China Non-Hodgkin Lymphoma Diagnostics Market Opportunity Assessment, By Cancer Stage, 2021 & 2031F |
9.3 China Non-Hodgkin Lymphoma Diagnostics Market Opportunity Assessment, By Tumor Type, 2021 & 2031F |
9.4 China Non-Hodgkin Lymphoma Diagnostics Market Opportunity Assessment, By Product, 2021 & 2031F |
9.5 China Non-Hodgkin Lymphoma Diagnostics Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.6 China Non-Hodgkin Lymphoma Diagnostics Market Opportunity Assessment, By Application, 2021 & 2031F |
9.7 China Non-Hodgkin Lymphoma Diagnostics Market Opportunity Assessment, By End User, 2021 & 2031F |
9.7 China Non-Hodgkin Lymphoma Diagnostics Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 China Non-Hodgkin Lymphoma Diagnostics Market - Competitive Landscape |
10.1 China Non-Hodgkin Lymphoma Diagnostics Market Revenue Share, By Companies, 2024 |
10.2 China Non-Hodgkin Lymphoma Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |